Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase III trial begins for theragnostic drug in patients with progressive midgut carcinoid

Sep. 20, 2012

International partnership initiates phase II study of PI3K inhibitor in breast cancer

Sep. 19, 2012

Chugai files for approval of Avastin for additional indication in Japan

Sep. 19, 2012

Eternity Biosciences prepares new protein kinase inhibitors

Sep. 19, 2012

MT-102 improves heart function in rat model of cancer cachexia

Sep. 19, 2012

Crizotinib effective in patients with NSCLC harboring ROS1 gene rearrangement

Sep. 19, 2012

Merck KGaA voluntarily withdraws European application for Erbitux in NSCLC

Sep. 18, 2012

JASPAC1 01 phase III interim study results to be published

Sep. 18, 2012

Promising in vitro and in vivo results reported for novel dual c-Met/Ron inhibitor

Sep. 18, 2012

Nerviano Medical Sciences presents novel B-raf inhibitors

Sep. 18, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...